{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T01:44:23Z","timestamp":1792547063837,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"7-8","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.canrad.2025.104760","type":"journal-article","created":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T09:14:54Z","timestamp":1763025294000},"page":"104760","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Radiotherapy for lung metastases"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4798-8899","authenticated-orcid":false,"given":"Antonin","family":"Levy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Tonneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9179-746X","authenticated-orcid":false,"given":"Julien","family":"Darr\u00e9on","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8391-1541","authenticated-orcid":false,"given":"Jonathan","family":"Khalifa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3349-2529","authenticated-orcid":false,"given":"Delphine","family":"Antoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2935-1843","authenticated-orcid":false,"given":"Eivind","family":"Blais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5284-2957","authenticated-orcid":false,"given":"C\u00e9cile","family":"Le P\u00e9choux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7286-1350","authenticated-orcid":false,"given":"Delphine","family":"Lerouge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4776-115X","authenticated-orcid":false,"given":"Fran\u00e7ois","family":"Lucia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Marguerit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3774-8288","authenticated-orcid":false,"given":"\u00c9tienne","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9796-3553","authenticated-orcid":false,"given":"Baptiste","family":"Pichon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Pourel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8232-0056","authenticated-orcid":false,"given":"Fran\u00e7ois-Georges","family":"Riet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5772-2336","authenticated-orcid":false,"given":"Philippe","family":"Giraud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2281-3999","authenticated-orcid":false,"given":"S\u00e9bastien","family":"Thureau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"25","key":"10.1016\/j.canrad.2025.104760_bib0005","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1200\/JCO.20.00818","article-title":"Stereotactic ablative radiotherapy for the comprehensive treatment of oligometastatic cancers: long-term results of the SABR-COMET phase II randomized trial","volume":"38","author":"Palma","year":"2020","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.canrad.2025.104760_bib0010","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1016\/j.jtho.2019.07.025","article-title":"Definition of synchronous oligometastatic non-small cell lung cancer-a consensus report","volume":"14","author":"Dingemans","year":"2019","journal-title":"J Thorac Oncol"},{"issue":"1","key":"10.1016\/j.canrad.2025.104760_bib0015","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1016\/S1470-2045(19)30718-1","article-title":"Characterisation and classification of oligometastatic disease: a European society for radiotherapy and oncology and European organisation for research and treatment of cancer consensus recommendation","volume":"21","author":"Guckenberger","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2025.104760_bib0020","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ejca.2017.12.012","article-title":"Strategies and technical challenges for imaging oligometastatic disease: recommendations from the European organisation for research and treatment of cancer imaging group","volume":"91","author":"deSouza","year":"2018","journal-title":"Eur J Cancer"},{"issue":"18","key":"10.1016\/j.canrad.2025.104760_bib0025","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1200\/JCO.19.00201","article-title":"Local consolidative therapy vs. maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer: long-term results of a multi-institutional, phase II, randomized study","volume":"37","author":"Gomez","year":"2019","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.canrad.2025.104760_bib0030","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.ijrobp.2022.05.033","article-title":"Progression-free survival and local control after SABR for up to 5 oligometastases: an analysis from the population-based phase 2 SABR-5 trial","volume":"114","author":"Baker","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"10.1016\/j.canrad.2025.104760_bib0035","doi-asserted-by":"crossref","first-page":"e622","DOI":"10.1016\/j.cllc.2020.05.013","article-title":"Consolidative radiotherapy in oligometastatic lung cancer: patient selection with a prediction nomogram","volume":"21","author":"Friedes","year":"2020","journal-title":"Clin Lung Cancer"},{"issue":"3","key":"10.1016\/j.canrad.2025.104760_bib0040","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1177\/0300891618766820","article-title":"Stereotactic body radiotherapy for lung oligometastases: Literature review according to PICO criteria","volume":"104","author":"Alongi","year":"2018","journal-title":"Tumori"},{"issue":"11","key":"10.1016\/j.canrad.2025.104760_bib0045","doi-asserted-by":"crossref","first-page":"e2026312","DOI":"10.1001\/jamanetworkopen.2020.26312","article-title":"Evaluation of definitive stereotactic body radiotherapy and outcomes in adults with extracranial oligometastasis","volume":"3","author":"Poon","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"5","key":"10.1016\/j.canrad.2025.104760_bib0050","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.cllc.2014.04.003","article-title":"An individual patient data metaanalysis of outcomes and prognostic factors after treatment of oligometastatic non-small-cell lung cancer","volume":"15","author":"Ashworth","year":"2014","journal-title":"Clin Lung Cancer"},{"issue":"2","key":"10.1016\/j.canrad.2025.104760_bib0055","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.radonc.2017.01.003","article-title":"Nomogram based overall survival prediction in stereotactic body radiotherapy for oligometastatic lung disease","volume":"123","author":"Tanadini-Lang","year":"2017","journal-title":"Radiother Oncol"},{"issue":"10","key":"10.1016\/j.canrad.2025.104760_bib0060","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1093\/annonc\/mdu370","article-title":"Phase II study of stereotactic body radiotherapy to primary tumor and metastatic locations in oligometastatic nonsmall-cell lung cancer patients","volume":"25","author":"Collen","year":"2014","journal-title":"Ann Oncol"},{"issue":"10","key":"10.1016\/j.canrad.2025.104760_bib0065","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1007\/s00066-018-1335-x","article-title":"Prognostic factors in stereotactic body radiotherapy of lung metastases","volume":"194","author":"Borm","year":"2018","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.canrad.2025.104760_bib0070","doi-asserted-by":"crossref","first-page":"109848","DOI":"10.1016\/j.radonc.2023.109848","article-title":"Ten years outcomes after SABR in central and ultracentral primary lung tumors","volume":"188","author":"Tekatli","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2025.104760_bib0075","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.radonc.2019.11.001","article-title":"Variation in current prescription practice of stereotactic body radiotherapy for peripherally located early stage non-small cell lung cancer: Recommendations for prescribing and recording according to the ACROP guideline and ICRU report 91","volume":"142","author":"de Jong","year":"2020","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.canrad.2025.104760_bib0080","doi-asserted-by":"crossref","first-page":"254","DOI":"10.6004\/jnccn.2021.0013","article-title":"NCCN guidelines insights: non-small cell lung cancer, version 2.2021","volume":"19","author":"Ettinger","year":"2021","journal-title":"J Natl Compr Canc Netw"},{"issue":"10","key":"10.1016\/j.canrad.2025.104760_bib0085","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1001\/jamaoncol.2021.2939","article-title":"Single-fraction vs multifraction stereotactic ablative body radiotherapy for pulmonary oligometastases (SAFRON II): the Trans Tasman Radiation Oncology Group 13.01 phase 2 randomized clinical trial","volume":"7","author":"Siva","year":"2021","journal-title":"JAMA Oncol"},{"issue":"8","key":"10.1016\/j.canrad.2025.104760_bib0090","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.clon.2020.05.001","article-title":"Reduced fractionation in lung cancer patients treated with curative-intent radiotherapy during the covid-19 pandemic","volume":"32","author":"Faivre-Finn","year":"2020","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"4","key":"10.1016\/j.canrad.2025.104760_bib0095","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.ijrobp.2019.08.019","article-title":"One versus three fractions of stereotactic body radiation therapy for peripheral stage I to II non-small cell lung cancer: a randomized, multi-institution, phase 2 trial","volume":"105","author":"Singh","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.canrad.2025.104760_bib0100","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.ijrobp.2015.07.2260","article-title":"A randomized phase 2 study comparing 2 stereotactic body radiation therapy schedules for medically inoperable patients with stage I peripheral non-small cell lung cancer: NRG Oncology RTOG 0915 (NCCTG N0927)","volume":"93","author":"Videtic","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.canrad.2025.104760_bib0105","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.ijrobp.2018.11.051","article-title":"Long-term follow-up on NRG Oncology RTOG 0915 (NCCTG N0927): a randomized phase 2 study comparing 2 stereotactic body radiation therapy schedules for medically inoperable patients with stage I peripheral non-small cell lung cancer","volume":"103","author":"Videtic","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"15","key":"10.1016\/j.canrad.2025.104760_bib0110","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1200\/JCO.18.00622","article-title":"Safety and efficacy of a five-fraction stereotactic body radiotherapy schedule for centrally located non-small-cell lung cancer: NRG Oncology\/RTOG 0813 trial","volume":"37","author":"Bezjak","year":"2019","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.canrad.2025.104760_bib0115","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.jtho.2024.05.366","article-title":"Stereotactic body radiotherapy for centrally located inoperable early-stage NSCLC: EORTC 22113-08113 LungTech phase II trial results","volume":"19","author":"Levy","year":"2024","journal-title":"J Thorac Oncol"},{"issue":"7","key":"10.1016\/j.canrad.2025.104760_bib0120","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.jtho.2021.03.019","article-title":"The HILUS-Trial-a prospective nordic multicenter phase 2 study of ultracentral lung tumors treated with stereotactic body radiotherapy","volume":"16","author":"Lindberg","year":"2021","journal-title":"J Thorac Oncol"},{"issue":"3","key":"10.1016\/j.canrad.2025.104760_bib0125","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.ijrobp.2024.03.050","article-title":"Stereotactic radiation for ultracentral non-small cell lung cancer: a safety and efficacy trial (SUNSET)","volume":"120","author":"Giuliani","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2025.104760_bib0130","doi-asserted-by":"crossref","first-page":"110605","DOI":"10.1016\/j.radonc.2024.110605","article-title":"Toxicity in patients receiving radiotherapy for ultracentral stage I non-small cell lung cancer: a secondary analysis of the LUSTRE randomized trial","volume":"202","author":"Wu","year":"2024","journal-title":"Radiother Oncol"},{"issue":"11","key":"10.1016\/j.canrad.2025.104760_bib0135","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1001\/jamaoncol.2024.3089","article-title":"Stereotactic vs hypofractionated radiotherapy for inoperable stage I non-small cell lung cancer","volume":"10","author":"Swaminath","year":"2024","journal-title":"JAMA Oncol"},{"issue":"8","key":"10.1016\/j.canrad.2025.104760_bib0140","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1080\/0284186X.2021.1942545","article-title":"Ultra-central lung tumors: safety and efficacy of protracted stereotactic body radiotherapy","volume":"60","author":"Lodeweges","year":"2021","journal-title":"Acta Oncol"},{"issue":"6","key":"10.1016\/j.canrad.2025.104760_bib0145","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1097\/JTO.0000000000000159","article-title":"Stereotactic body radiotherapy in patients with previous pneumonectomy: safety and efficacy","volume":"9","author":"Thompson","year":"2014","journal-title":"J Thorac Oncol"},{"issue":"3","key":"10.1016\/j.canrad.2025.104760_bib0150","doi-asserted-by":"crossref","first-page":"e121","DOI":"10.1016\/S1470-2045(22)00752-5","article-title":"Metastases-directed stereotactic body radiotherapy in combination with targeted therapy or immunotherapy: systematic review and consensus recommendations by the EORTC-ESTRO OligoCare consortium","volume":"24","author":"Kroeze","year":"2023","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.canrad.2025.104760_bib0155","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.ijrobp.2011.08.036","article-title":"Oligometastases treated with stereotactic body radiotherapy: long-term follow-up of prospective study","volume":"83","author":"Milano","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"10.1016\/j.canrad.2025.104760_bib0160","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1200\/JCO.2008.19.6386","article-title":"Multi-institutional phase I\/II trial of stereotactic body radiation therapy for lung metastases","volume":"27","author":"Rusthoven","year":"2009","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.canrad.2025.104760_bib0165","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ijrobp.2014.10.021","article-title":"Stereotactic body radiation therapy for oligometastases to the lung: a phase 2 study","volume":"91","author":"Nuyttens","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.canrad.2025.104760_bib0170","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.ijrobp.2022.08.028","article-title":"Stereotactic body radiation therapy for lung metastases from sarcoma in oligometastatic patients: a phase 2 study","volume":"114","author":"Navarria","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1\u20132","key":"10.1016\/j.canrad.2025.104760_bib0175","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.canrad.2021.09.006","article-title":"Respiratory motion management for external radiotherapy treatment","volume":"26","author":"Darr\u00e9on","year":"2022","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2025.104760_bib0180","series-title":"Gestion des mouvements internes en radioth\u00e9rapie externe\u00a0: dispositifs et mise en \u0153uvre pour le traitement des patients. Rapport SFPM no 38","author":"Ayadi-Zahra","year":"2020"},{"key":"10.1016\/j.canrad.2025.104760_bib0185","doi-asserted-by":"crossref","first-page":"104758","DOI":"10.1016\/j.canrad.2025.104758","article-title":"Delineation of organs at risk in radiotherapy and perspectives","volume":"29","author":"Eber","year":"2025","journal-title":"Cancer Radiother"},{"issue":"5","key":"10.1016\/j.canrad.2025.104760_bib0190","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.ijrobp.2010.07.1977","article-title":"Consideration of dose limits for organs at risk of thoracic radiotherapy: atlas for lung, proximal bronchial tree, esophagus, spinal cord, ribs, and brachial plexus","volume":"81","author":"Kong","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.canrad.2025.104760_bib0195","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.radonc.2017.05.012","article-title":"ESTRO ACROP consensus guideline on implementation and practice of stereotactic body radiotherapy for peripherally located early stage non-small cell lung cancer","volume":"124","author":"Guckenberger","year":"2017","journal-title":"Radiother Oncol"},{"issue":"5","key":"10.1016\/j.canrad.2025.104760_bib0200","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/COC.0000000000001079","article-title":"ACR-ARS practice parameter for radiation oncology","volume":"47","author":"Lo","year":"2024","journal-title":"Am J Clin Oncol"},{"issue":"5","key":"10.1016\/j.canrad.2025.104760_bib0205","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1002\/mp.12193","article-title":"Still equivalent for dose calculation in the Monte Carlo era? A comparison of free breathing and average intensity projection CT datasets for lung SBRT using three generations of dose calculation algorithms","volume":"44","author":"Zvolanek","year":"2017","journal-title":"Med Phys"},{"issue":"7","key":"10.1016\/j.canrad.2025.104760_bib0210","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1118\/1.3598434","article-title":"Management of the baseline shift using a new and simple method for respiratory-gated radiation therapy: detectability and effectiveness of a flexible monitoring system","volume":"38","author":"Tachibana","year":"2011","journal-title":"Med Phys"},{"issue":"1\u20132","key":"10.1016\/j.canrad.2025.104760_bib0215","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.canrad.2021.11.001","article-title":"Organs at risk radiation dose constraints","volume":"26","author":"No\u00ebl","year":"2022","journal-title":"Cancer Radiother"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321825001763?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321825001763?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T12:16:09Z","timestamp":1768738569000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321825001763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":43,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S1278321825001763"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2025.104760","relation":{},"ISSN":["1278-3218"],"issn-type":[{"value":"1278-3218","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiotherapy for lung metastases","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2025.104760","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104760"}}